Markus Müschen
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Lymphoblastic Leukemia research 70
-
- DNA Repair Mechanisms 9
- Co-authors
- Klaus Rajewsky (6 shared papers)Ralf Küppers (6 shared papers)Hassan Jumaa (28 shared papers)Ulrich Warskulat (4 shared papers)Huimin Geng (37 shared papers)Matthias W. Beckmann (2 shared papers)Michael R. Lieber (8 shared papers)Florian Klein (8 shared papers)
- Journals
- Blood (76 papers)The Journal of Experimental Medicine (7 papers)Proceedings of the National Academy of Sciences (6 papers)Cancer Research (5 papers)Nature Communications (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Markus Müschen
160 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 111
- Hematology 930
- Genetics 769
- Immunology 1.1k
- Pathology and Forensic Medicine 667
- Oncology 1.0k
Countries citing papers authored by Markus Müschen
This map shows the geographic impact of Markus Müschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Müschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Müschen more than expected).
Fields of papers citing papers by Markus Müschen
This network shows the impact of papers produced by Markus Müschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Müschen. The network helps show where Markus Müschen may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Müschen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 226 | |
| 2 | 2008 | 172 | |
| 3 | 2000 | 156 | |
| 4 | 2011 | 139 | |
| 5 | 2000 | 133 | |
| 6 | 2012 | 128 | |
| 7 | 2015 | 127 | |
| 8 | 2009 | 121 | |
| 9 | 2000 | 117 | |
| 10 | 2013 | 110 | |
| 11 | Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. | 2001 | 110 |
| 12 | 2009 | 92 | |
| 13 | 2018 | 92 | |
| 14 | 2013 | 89 | |
| 15 | 2016 | 84 | |
| 16 | 2015 | 81 | |
| 17 | 2014 | 80 | |
| 18 | 2011 | 79 | |
| 19 | 2016 | 79 | |
| 20 | Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells. | 2000 | 74 |
About Markus Müschen
Markus Müschen is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Hematology, Genetics and Immunology, having authored 166 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (70 papers), Chronic Lymphocytic Leukemia Research (50 papers), Chronic Myeloid Leukemia Treatments (49 papers), Immune Cell Function and Interaction (18 papers), Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (16 papers), Acute Myeloid Leukemia Research (10 papers) and DNA Repair Mechanisms (9 papers). The work is most often cited by research in Hematology (930 citations), Genetics (769 citations), Immunology (1.1k citations), Pathology and Forensic Medicine (667 citations) and Oncology (1.0k citations). Markus Müschen has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Klaus Rajewsky, Ralf Küppers, Hassan Jumaa, Ulrich Warskulat, Huimin Geng, Matthias W. Beckmann, Michael R. Lieber, Florian Klein, Daniel Ré and Volker Diehl. Their work appears in journals such as Blood, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.